Advocating for mutually beneficial access to shelved compounds

著录项

• 来源
  《Future medicinal chemistry》 |2018年第12期|共4页
• 作者

  Pulley Jill M.; Jerome Rebecca N.; Shirey-Rice Jana K.; Zaleski Nicole M.; Naylor Helen M.; Pruijssers Andrea J.; Jackson James C.; Bernard Gordon R.; Holroyd Kenneth J.;

  展开▼
• 作者单位

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  Vanderbilt Univ Med Ctr Ctr Knowledge Management 3401 West End Ave Suite 304 Nashville TN;

  Vanderbilt Univ Sch Med Div Infect Dis Dept Pediat 1161 21st Ave South Nashville TN 37232 USA;

  Vanderbilt Univ Sch Med Div Allergy Pulm &

  Crit Care Med Dept Med 1161 21st Ave South;

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  Vanderbilt Univ Med Ctr Vanderbilt Inst Clin &

  Translat Res 2525 West End Ave Suite 600;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 药学;
• 关键词

  drug industry; drug repurposing; government regulation; nelivaptan; shelved compounds; tax incentives;

  机译：药业;毒品重新施肥;政府监管;Nelivaptan;搁置化合物;税收激励措施;